Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)

Barry M. Massie, Martin R. Berk, Susan C. Brozena, Uri Elkayam, Jonathan F. Plehn, Marrick L. Kukin, Milton Packer, Bruce E. Murphy, Gerald W. Neuberg, Richard M. Steingart, T. Barry Levine, Hans DeHaan

Research output: Contribution to journalArticle

90 Scopus citations

Fingerprint Dive into the research topics of 'Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)'. Together they form a unique fingerprint.

Medicine & Life Sciences